Results
|
299701.
|
|
|
299702.
|
|
|
299703.
|
|
|
299704.
|
|
|
299705.
|
|
|
299706.
|
|
|
299707.
|
|
|
299708.
|
|
|
299709.
|
|
|
299710.
|
Erratum for the Research Article: "Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans" by G. Reyes-Soffer, B. Moon, A. Hernandez-Ono, M. Dionizovick-Dimanovski, J. Jimenez, J. Obunike, T. Thomas, C. Ngai, N. Fontanez, D. S. Donovan, W. Karmally, S. Holleran, R. Ramakrishnan, R. S. Mittleman, H. N. Ginsberg. [electronic resource] Producer: 20160620
In:
Science translational medicine vol. 8
Availability: No items available.
|
|
299711.
|
A concise and efficient concurrent synthesis of 6,11-dihydrodibenzo[b,e]azepines and 5,6,11,12-tetrahydrodibenzo[b,f]azocines and their conversion to 4-oxo-8,13-dihydro-4H-benzo[5,6]azepino[3,2,1-ij]quinoline-5-carboxylates and N-acetyl-5,6,11,12-tetrahydrodibenzo[b,f]azocines: synthetic sequence, spectroscopic characterization and the structures of two products. [electronic resource] by
Publication details: Acta crystallographica. Section C, Structural chemistry Jun 2019
In:
Acta crystallographica. Section C, Structural chemistry vol. 75
Availability: No items available.
|
|
299712.
|
|
|
299713.
|
|
|
299714.
|
|
|
299715.
|
|
|
299716.
|
|
|
299717.
|
|
|
299718.
|
|
|
299719.
|
Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996). [electronic resource] by
- Sircar, I
- Hodges, J C
- Quin, J
- Bunker, A M
- Winters, R T
- Edmunds, J J
- Kostlan, C R
- Connolly, C
- Kesten, S J
- Hamby, J M
Producer: 19930924
In:
Journal of medicinal chemistry vol. 36
Availability: No items available.
|
|
299720.
|
Total Synthesis of Colombiasin A This work was financially supported by the National Institutes of Health (USA) and The Skaggs Institute for Chemical Biology, postdoctoral fellowships from Bayer AG (to R.K. and W.M.), and grants from Abbott, Amgen, ArrayBiopharma, Boehringer-Ingelheim, Glaxo, Hoffmann-La Roche, DuPont, Merck, Novartis, Pfizer, and Schering Plough. [electronic resource] by
Publication details: Angewandte Chemie (International ed. in English) Jul 2001
In:
Angewandte Chemie (International ed. in English) vol. 40
Availability: No items available.
|